Letters to the Editor

• New Data About Atrial Fibrillation, Comment to the OFRECE Study

  Rafael Vidal-Pérez, Fernando Otero-Raviña, Manuel Otero-Mata, José Ramón González-Juanatey

  Rev Esp Cardiol. 2014;67:499

• Use of Antithrombotic Therapy in Patients With Atrial Fibrillation in Primary Care. Importance of INR Control

  Mariano Leal-Hernández, Francisco Marín

  Rev Esp Cardiol. 2014;67:419

• Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation?

  Eva Pueo, Bieito Campos, Manuel Anguita, Fernando Worner

  Rev Esp Cardiol. 2014;67:417-8

• Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? Response

  Vivencio Barrios, Carlos Escobar

  Rev Esp Cardiol. 2014;67:418

• Use of Antithrombotic Therapy in Patients With Atrial Fibrillation in Primary Care. Importance of INR Control. Response

  Carlos Escobar, Vivencio Barrios

  Rev Esp Cardiol. 2014;67:420

• Emergency Physicians Also Knocking on the Door of Echocardiography. Response

  Miguel Angel Garcia Fernandez

  Rev Esp Cardiol. 2014;67:332-3

• Emergency Physicians Also Knocking on the Door of Echocardiography

  Javier Jacob, Ferran Llopis, Xavier Palom, Ignasi Bardes

  Rev Esp Cardiol. 2014;67:332

• Usefulness of Genetic Diagnosis in a Woman With Hypertrophic Cardiomyopathy and the Desire for Motherhood: Information Is Key. Response

  Eduardo Villacorta, Eduardo Zatarain-Nicolás, Pedro L. Sánchez, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2014;67:334

• Usefulness of Genetic Diagnosis in a Woman With Hypertrophic Cardiomyopathy and the Desire for Motherhood: Information Is Key

  Roberto Barriales-Villa, Diego A. García-Giustiniani, Martin Ortiz-Genga, Lorenzo Monserrat

  Rev Esp Cardiol. 2014;67:333-4

• Time Since Diabetes Onset as a Determining Factor in Platelet Reactivity. Response

  David Vivas, Antonio Fernández-Ortiz

  Rev Esp Cardiol. 2014;67:244

• Home Subcutaneous Infusion of Furosemide in Advanced Decompensated Heart Failure

  Miguel A. Sancho-Zamora

  Rev Esp Cardiol. 2014;67:241-2

• Home Subcutaneous Infusion of Furosemide in Advanced Decompensated Heart Failure. Response

  Eduardo Zatarain-Nicolás, Luis de la Fuente-Galán, José Alberto San Román-Calvar

  Rev Esp Cardiol. 2014;67:242

• Time Since Diabetes Onset as a Determining Factor in Platelet Reactivity

  Jesús Maria de la Hera Galarza, Jose Manuel García-Ruiz, Elías Delgado Alvarez, José Luis Ferreiro

  Rev Esp Cardiol. 2014;67:243

• Atrial Fibrillation in Cryptogenic Stroke: New Tools Needed for Diagnosis?

  Sandra Secades-González, María Martín-Fernández, Jesús M. de la Hera-Galarza, Sergio Calleja-Puerta

  Rev Esp Cardiol. 2014;67:160-1

• Massive Left Ventricular Calcification: Related to Endomyocardial Fibrosis or Idiopathic? Response

  Xacobe Flores Ríos, Pablo Piñón Esteban, Alfonso Castro Beiras

  Rev Esp Cardiol. 2014;67:160

• Massive Left Ventricular Calcification: Related to Endomyocardial Fibrosis or Idiopathic?

  Luiz A. Benvenuti, Vera M.C. Salemi

  Rev Esp Cardiol. 2014;67:159

• Comments on the Analysis of Telephone Calls to a Heart Failure Unit: Reasons for the Call and Resource Use. Response

  Josep Lupón, Beatriz González, Mar Domingo, Antoni Bayes-Genis

  Rev Esp Cardiol. 2014;67:158-9

• Comments on the Analysis of Telephone Calls to a Heart Failure Unit: Reasons for the Call and Resource Use

  Ana R. Alconero-Camarero, Carlos Hernández-Jiménez, María A. Pellico-López

  Rev Esp Cardiol. 2014;67:157-8

• Appropriate Use Criteria for Cardiopulmonary Exercise Testing in Patients With Cardiac Resynchronization Devices

  Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez

  Rev Esp Cardiol. 2014;67:156

• Appropriate Use Criteria for Cardiopulmonary Exercise Testing in Patients With Cardiac Resynchronization Devices. Response

  Marta de Riva-Silva, María López-Gil, Adolfo Fontenla-Cerezuela, Fernando Arribas-Ynsaurriaga

  Rev Esp Cardiol. 2014;67:157